Newsroom

Sorted by: Latest

-

Vehicle Management Solutions Awarded West Virginia Department of Highways Courtesy Patrol Contract

TINLEY PARK, Ill.--(BUSINESS WIRE)--Vehicle Management Solutions (“VMS” or the “Company”), a portfolio company of Mill Point Capital LLC (“Mill Point”), today announced that its Safety Service Patrol (“SSP”) division has been awarded the West Virginia Department of Highways (“WVDOH”) Courtesy Patrol contract, reinforcing VMS’s long-standing role as a trusted partner to public transportation agencies nationwide. VMS brings deep, institutional experience operating West Virginia’s statewide Courte...
-

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for relacorilant as a treatment for patients with Cushing’s syndrome.As requested by t...
-

Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)

PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) and Spero Therapeutics (Nasdaq: SPRO) today announced that the US Food and Drug Administration (FDA) has approved Utebzi, an oral antibiotic for the treatment of complicated urinary tract infections (cUTIs) including pyelonephritisi, caused by certain susceptible pathogensii in adult patients who have limited or no alternative oral treatment options. This is the first and only oral carbapenem antibiotic approved for these patients. This app...
-

Opsin Leads the Second Generation of Enterprise AI Security as Agents Move from Saying to Doing

SAN FRANCISCO--(BUSINESS WIRE)--Marquee customer wins, analyst recognition, and platform innovation underscore Opsin's leadership in governance for autonomous enterprise agents....
-

Merit Matters: Old Glory Bank Investing in the Next Generation of American Leaders

ELMORE CITY, Okla.--(BUSINESS WIRE)--Old Glory Bank has announced the recipient of its 2026 Merit Scholarship, recognizing achievement in academic excellence, leadership, and service....
-

Bristol Myers Squibb Announces Dividend

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Dividend...
-

Office Properties Income Trust Completes Chapter 11 Reorganization

NEWTON, Mass.--(BUSINESS WIRE)--Office Properties Income Trust (“OPI” or the “Company”) today announced that it has successfully completed its financial restructuring and has emerged from Chapter 11. OPI achieved its objectives to strengthen its balance sheet, reduce debt, and position the Company for long-term operational stability. Pursuant to OPI’s Chapter 11 Plan of Reorganization confirmed by the U.S. Bankruptcy Court for the Southern District of Texas on April 22, 2026, OPI entered into t...
-

TechnipFMC Announces Second-Quarter 2026 Earnings Release and Conference Call

NEWCASTLE & HOUSTON--(BUSINESS WIRE)--TechnipFMC (NYSE: FTI) will host its second-quarter 2026 earnings conference call on Thursday, July 30, 2026, at 1:30 p.m. London time (8:30 a.m. New York time). A press release announcing the results will be issued prior to the call at approximately 11:45 a.m. London time (6:45 a.m. New York time). The event will be webcast live and can be accessed via the Investor Relations website, or by registering here. A replay of the webcast will be available on the...
-

Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced detailed positive results from the Vibrance-2 phase 2 dose-ranging study evaluating alixorexton in patients with narcolepsy type 2 (NT2). Once-daily alixorexton met the study’s dual primary endpoints, demonstrating statistically significant and clinically meaningful improvements from baseline compared to placebo on the Maintenance of Wakefulness Test (MWT) and Epworth Sleepiness Scale (ESS) at week eight in adults with NT2 (n=...
-

Urban Edge Properties Invites You to Join Its Second Quarter 2026 Earnings Conference Call

NEW YORK--(BUSINESS WIRE)--Urban Edge Properties Invites You to Join Its Second Quarter 2026 Earnings Conference Call...